IntegraGen S.A.
ALINT.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.32 | -0.01 | 18.78 | -4.57 |
| FCF Yield | 0.00% | 0.00% | 5.03% | 5.61% |
| EV / EBITDA | -8.61 | -99.09 | 103.37 | 65.84 |
| Quality | ||||
| ROIC | -14.56% | -3.68% | -0.09% | 0.09% |
| Gross Margin | 20.53% | -0.06% | -0.05% | 0.39% |
| Cash Conversion Ratio | – | – | -230.15 | 26.73 |
| Growth | ||||
| Revenue 3-Year CAGR | -12.91% | 3.45% | 13.61% | 11.00% |
| Free Cash Flow Growth | 0.00% | -100.00% | -2.10% | -9.04% |
| Safety | ||||
| Net Debt / EBITDA | 4.25 | 13.52 | -11.26 | -10.20 |
| Interest Coverage | -166.12 | -21.96 | -11.67 | -6.05 |
| Efficiency | ||||
| Inventory Turnover | 33.72 | 40.28 | 33.19 | 32.93 |
| Cash Conversion Cycle | 95.05 | 95.94 | 63.19 | 71.95 |